| 251 |
16305071 | Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects. | 2005 Feb |
3 |
| 252 |
16340782 | Rosiglitazone therapy of posttransplant diabetes mellitus. | 2005 Nov 27 |
4 |
| 253 |
16483179 | The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome. | 2005 Dec |
2 |
| 254 |
14556646 | Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo. | 2004 Jan 15 |
5 |
| 255 |
14625208 | Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. | 2004 Apr |
1 |
| 256 |
14747233 | In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. | 2004 Feb |
4 |
| 257 |
14749206 | Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. | 2004 Jun |
3 |
| 258 |
14759393 | Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome. | 2004 Feb 1 |
1 |
| 259 |
15001452 | Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. | 2004 May |
2 |
| 260 |
15037412 | Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome. | 2004 Mar |
4 |
| 261 |
15038907 | Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation. | 2004 Apr |
1 |
| 262 |
15087762 | Rosiglitazone treatment of diabetes mellitus after solid organ transplantation. | 2004 Apr 15 |
2 |
| 263 |
15089784 | Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance. | 2004 May |
4 |
| 264 |
15120703 | Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents. | 2004 Mar-Apr |
2 |
| 265 |
15130377 | [Effect of rosiglitazone on ovulation induction in women with polycystic ovary syndrome]. | 2004 Mar |
1 |
| 266 |
15148065 | Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial. | 2004 May 18 |
2 |
| 267 |
15161787 | Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. | 2004 Jun |
2 |
| 268 |
15199366 | Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease. | 2004 Jun |
1 |
| 269 |
15243303 | Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity. | 2004 Aug |
2 |
| 270 |
15246889 | Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus. | 2004 Jul 15 |
1 |
| 271 |
15277403 | Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. | 2004 Aug |
3 |
| 272 |
15311106 | Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase. | 2004 Sep |
4 |
| 273 |
15343508 | Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. | 2004 Sep |
1 |
| 274 |
15482765 | Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. | 2004 Oct |
1 |
| 275 |
15504990 | Effect of rosiglitazone versus insulin on the pancreatic beta-cell function of subjects with type 2 diabetes. | 2004 Nov |
7 |
| 276 |
15510236 | Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes. | 2004 Jul |
1 |
| 277 |
15529521 | Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. | 2004 Sep |
2 |
| 278 |
15569129 | Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone. | 2004 Dec |
4 |
| 279 |
15579757 | Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin:insulin ratio in type 2 diabetes. | 2004 Dec |
11 |
| 280 |
15614340 | Rationale and design of the Glitazones and the Endothelium (GATE) study: evaluation of rosiglitazone on endothelial function in patients with diabetes. | 2004 Dec |
2 |
| 281 |
15628829 | Chronic heart failure-related interventions after starting rosiglitazone in patients receiving insulin. | 2004 Oct |
2 |
| 282 |
15641698 | Effect of rosiglitazone on endocrine, metabolism and ovulatory performance in patients with polycystic ovary syndrome and insulin resistance. | 2004 |
3 |
| 283 |
16114542 | [Effects of rosiglitazone on serum leptin and insulin resistance in patients with Type 2 diabetes]. | 2004 Dec |
3 |
| 284 |
16145910 | [Effect of rosiglitazone on level of serum TNF-alpha and its relation with insulin resistance in type 2 diabetes mellitus]. | 2004 Apr |
2 |
| 285 |
12467491 | The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment. | 2003 |
1 |
| 286 |
12502504 | Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats. | 2003 Jan |
2 |
| 287 |
12502676 | Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. | 2003 Jan |
3 |
| 288 |
12540598 | Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. | 2003 Feb |
3 |
| 289 |
12566086 | Diminished production of nitric oxide synthase cofactor tetrahydrobiopterin by rosiglitazone in adipocytes. | 2003 Feb 15 |
1 |
| 290 |
12593999 | Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy. | 2003 Feb |
4 |
| 291 |
12615670 | Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. | 2003 Apr 1 |
2 |
| 292 |
12620440 | Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. | 2003 Mar |
2 |
| 293 |
12663234 | Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. | 2003 Apr |
4 |
| 294 |
12670479 | PPAR gamma-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNF alpha secretion is not mediated by PTEN regulation. | 2003 Apr 11 |
1 |
| 295 |
12681023 | Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes. | 2003 May |
4 |
| 296 |
12752488 | Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients. | 2003 May |
1 |
| 297 |
12825962 | Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence. | 2003 |
2 |
| 298 |
12866663 | Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions. | 2003 Aug |
1 |
| 299 |
12878365 | Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus. | 2003 Aug |
1 |
| 300 |
12882907 | Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. | 2003 Aug |
3 |